Implementation of a disinfectant technology to control the spread of agents that cause Acute Respiratory Infection (ARI) with pandemic potential through the spraying of natural products

This project will carry out commercial validation under real operating conditions (TRL: 7-8) of a disinfectant technology based on natural ingredients obtained through clean extraction technologies. The proposed studies include adaptation of formulations, multiscale modeling, in vitro and in silico safety and efficacy testing, and evaluation in real-world environments. Some of the ingredients have been widely reported for their antimicrobial effect. One of them is one of the only natural agents included by the United States Environmental Protection Agency (EPA) in its N list (Products with declarations of use against emerging viral pathogens and human coronavirus SARS-CoV-2). The union of the university, the company and the state for the valuation and use of biodiversity, materializes in the development of useful products to face problems of humanity such as COVID-19. In addition to the effects on public health, this project opens up great possibilities for the communities that produce the raw materials used in the project.